Publications by authors named "Theodore C Rozema"
Article Synopsis
- The TACT study evaluated the long-term effects of EDTA chelation therapy on patients with stable coronary disease, finding that it reduced the risk of major cardiovascular events.
- Quality of life measures, including the Duke Activity Status Index and Mental Health Inventory, showed no significant differences between the chelation and placebo groups over a 2-year period.
- Overall, the study concluded that EDTA chelation therapy did not improve quality of life in patients post-myocardial infarction despite its benefits in reducing certain health risks.